Redesign of Everyday Activities and Lifestyle With Occupational Therapy for Chronic Pain Patients
Launched by SLAGELSE HOSPITAL · Apr 3, 2019
Trial Information
Current as of June 09, 2025
Completed
Keywords
ClinConnect Summary
Methods
Design
The feasibility study is designed as a mixed-methods single-arm case series pretest-posttest study. The feasibility of the planned intervention course and the assessment procedures will be evaluated. Forty-eight adults aged 18-65 will receive the lifestyle-oriented OT intervention for 15 weeks in addition to the current multidisciplinary CNMP treatment. The participants will complete assessments for Quality of Life (EQ-5D-5L), Occupational performance (COPM, AMPS), Occupational balance (OBQ), Pain-related Self-efficacy (PSEQ), Physical wake-time activity (actigraphs), BMI (...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Age ≥ 18\<65yr, chronic non-malignant pain diagnosis present ≥ 3 mths at the inclusion
- Exclusion Criteria:
- • Acute/ sub-acute pain; cancer-related pain; unstable medicine intake over the past four weeks; daily opioid intake \>30 mg; headache/migraine; currently diagnosed depression; current substance misuse; severe psychiatric diagnosis; poor Danish speaking skills and participating in other CNMP-treatment programs. Severe psychiatric diagnoses are defined as a mental illness involving distortion in thinking and perception, and leading to significant social and occupational dysfunction, e.g. schizophrenia and schizotypal, delusional, schizoaffective or psychotic disorders, or psychosis.
- • Both, new eligible patients, and those who fulfill the eligibility criteria after an initial opioid intake adjustment course, will be considered.
About Slagelse Hospital
Slagelse Hospital is a leading healthcare institution dedicated to providing high-quality medical care and advancing clinical research. As a prominent clinical trial sponsor, the hospital focuses on innovative studies aimed at improving patient outcomes and enhancing treatment methodologies across various medical disciplines. With a commitment to ethical standards and patient safety, Slagelse Hospital collaborates with multidisciplinary teams of healthcare professionals and researchers to explore new therapeutic approaches and contribute to the advancement of medical knowledge. Through its robust clinical trial programs, the hospital strives to address pressing health challenges and foster a culture of scientific inquiry and excellence in patient care.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Slagelse, Zealand Region, Denmark
Patients applied
Trial Officials
Jeanette R. Christensen, OT, PhD
Principal Investigator
Department of Public Health, University of Southern Denmark
Soeren T. Skou, PT, PhD
Study Director
Slagelse Hosp.; Dept. of Sports Science & Clin. Biomechanics, Univ. of South. DK
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials